Evidence map›Paper›PMID 37620051›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2023

Ethical Considerations for Artificial Intelligence in Medical Imaging: Deployment and Governance.

Jonathan Herington, Melissa D McCradden, Kathleen Creel, Ronald Boellaard, Elizabeth C Jones, Abhinav K Jha, Arman Rahmim, Peter J H Scott, John J Sunderland, Richard L Wahl and 2 more

Abstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Applications of artificial intelligence in nuclear medicine.Zeitschrift fur medizinische Physik · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. [Analysis of the global registration status of clinical trials for artificial intelligence medical device].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2025
    Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jonathan HeringtonDepartment of Health Humanities and Bioethics and Department of Philosophy, University of Rochester, Rochester, New York.
Melissa D McCraddenDepartment of Bioethics, Hospital for Sick Children, and Dana Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Kathleen CreelDepartment of Philosophy and Religion and Khoury College of Computer Sciences, Northeastern University, Boston, Massachusetts.
Ronald BoellaardDepartment of Radiology and Nuclear Medicine, Cancer Centre Amsterdam, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Elizabeth C JonesDepartment of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland.
Abhinav K JhaDepartment of Biomedical Engineering and Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri.
Arman RahmimDepartments of Radiology and Physics, University of British Columbia, Vancouver, British Columbia, Canada.
Peter J H ScottDepartment of Radiology, University of Michigan Medical School, Ann Arbor, Michigan.
John J SunderlandDepartments of Radiology and Physics, University of Iowa, Iowa City, Iowa.
Richard L WahlMallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri; and.
Sven ZuehlsdorffSiemens Medical Solutions USA, Inc., Hoffman Estates, Illinois babak.saboury@nih.gov.
Babak SabouryDepartment of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland; babak.saboury@nih.gov.

Funding

Synthesis of Novel PET Radiotracers for Imaging in Alzheimer’s Disease and Related DisordersR01EB021155 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SANFORD, MELANIE S., SCOTT, PETER JAMES HENRY · 2016 to 2024
$3.2M
A no-gold-standard framework to objectively evaluate quantitative imaging methods with patient dataR01EB031051 · NIBIB · WASHINGTON UNIVERSITY · PI JHA, ABHINAV K · 2021 to 2025
$2.1M
NIBIB NIH HHS R01 EB021155NIBIB NIH HHS R01 EB031051
6 · The paper itself

Abstract

The deployment of artificial intelligence (AI) has the potential to make nuclear medicine and medical imaging faster, cheaper, and both more effective and more accessible. This is possible, however, only if clinicians and patients feel that these AI medical devices (AIMDs) are trustworthy. Highlighting the need to ensure health justice by fairly distributing benefits and burdens while respecting individual patients' rights, the AI Task Force of the Society of Nuclear Medicine and Molecular Imaging has identified 4 major ethical risks that arise during the deployment of AIMD: autonomy of patients and clinicians, transparency of clinical performance and limitations, fairness toward marginalized populations, and accountability of physicians and developers. We provide preliminary recommendations for governing these ethical risks to realize the promise of AIMD for patients and populations.

Indexed as

Nuclear MedicinePhysiciansAdvisory CommitteesArtificial IntelligenceHumansMolecular ImagingAI ethicsexplainabilityfairnessjusticesoftware as medical device

Identifiers

PMID37620051
PMCPMC12782051

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.